157 related articles for article (PubMed ID: 6186495)
1. Evaluation of pregnancy-specific beta 1-glycoprotein in patients with non-seminomatous testicular germ cell tumors.
de Bruijn HW; Suurmeijer AJ; Sleijfer DT; Koops HS; Ockhuizen T; Willemse PH; Marrink J
Eur J Cancer Clin Oncol; 1982 Oct; 18(10):911-6. PubMed ID: 6186495
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
3. Significance of human chorionic gonadotropin, alpha-fetoprotein, and pregnancy-specific beta-1-glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors.
de Bruijn HW; Sleijfer DT; Schraffordt Koops H; Suurmeijer AJ; Marrink J; Ockhuizen T
Cancer; 1985 Feb; 55(4):829-35. PubMed ID: 2578303
[TBL] [Abstract][Full Text] [Related]
4. Non-seminomatous germ cell tumors of the testis. Immunohistochemical localization and serum levels of human chorionic gonadotropin (HCG) and pregnancy-specific beta-1 glycoprotein (SP-1); value of SP-1 as a tumor marker.
Suurmeijer AJ; De Bruijn HW; Oosterhuis JW; Sleyfer DT; Koops HS; Fleuren GJ
Oncodev Biol Med; 1982; 3(5-6):409-22. PubMed ID: 6292873
[TBL] [Abstract][Full Text] [Related]
5. Correlation of serum tumor markers in advanced germ cell tumors with responses to chemotherapy and surgery.
Vugrin D; Friedman A; Whitmore WF
Cancer; 1984 Mar; 53(6):1440-5. PubMed ID: 6198071
[TBL] [Abstract][Full Text] [Related]
6. Trophoblastic proteins as tumor markers in nonseminomatous germ cell tumors.
Braunstein GD; Thompson R; Princler GL; McIntire KR
Cancer; 1986 May; 57(9):1842-5. PubMed ID: 2420442
[TBL] [Abstract][Full Text] [Related]
7. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
[TBL] [Abstract][Full Text] [Related]
8. Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumors.
Arrieta O; Michel Ortega RM; Angeles-Sánchez J; Villarreal-Garza C; Avilés-Salas A; Chanona-Vilchis JG; Aréchaga-Ocampo E; Luévano-González A; Jiménez MA; Aguilar JL
J Exp Clin Cancer Res; 2009 Aug; 28(1):120. PubMed ID: 19709439
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
[TBL] [Abstract][Full Text] [Related]
10. The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):129-34. PubMed ID: 6170953
[TBL] [Abstract][Full Text] [Related]
11. Cellular localization of AFP, hCG and its free subunits, and SP1 in embryonal carcinoma of the testis and ovary.
Furumoto M
Pathol Res Pract; 1981 Dec; 173(1-2):12-21. PubMed ID: 6174958
[TBL] [Abstract][Full Text] [Related]
12. [Pregnancy-specific beta 1-glycoprotein: a tumor marker].
Horne CH; Bremner RD
Ric Clin Lab; 1984; 14 Suppl 2():33-8. PubMed ID: 6085182
[No Abstract] [Full Text] [Related]
13. Prognostic significance of marker half-life during chemotherapy in non-seminomatous germ cell testicular tumors.
Inanç SE; Meral R; Darendeliler E; Yasasever V; Onat H
Acta Oncol; 1999; 38(4):505-9. PubMed ID: 10418719
[TBL] [Abstract][Full Text] [Related]
14. Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.
Nørgaard-Pedersen B; Schultz HP; Arends J; Brincker H; Krag Jacobsen G; Lindeløv B; Rørth M; Svennekjaer IL
Acta Radiol Oncol; 1984; 23(4):287-94. PubMed ID: 6208749
[TBL] [Abstract][Full Text] [Related]
15. Serum AFP, hCG and CEA in the management of patients with testicular, ovarian and extragonadal germ cell tumors.
Motawy MS; Szymendera JJ; al-Jazzaf H; Behbehani AE; Foudeh MO; Ebraheem AK; Nasralla MY; Ali MA
Int J Biol Markers; 1992; 7(2):80-6. PubMed ID: 1378875
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
You B; Fronton L; Boyle H; Droz JP; Girard P; Tranchand B; Ribba B; Tod M; Chabaud S; Coquelin H; Fléchon A
Urology; 2010 Aug; 76(2):423-9.e2. PubMed ID: 20472276
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical study of testicular tumor on cellular localization of HCG beta-subunit, alpha-fetoprotein and beta 1-pregnancy specific glycoprotein (author's transl)].
Shimatani N; Arakawa S; Ohno S; Kamidono S; Yoshimoto Y; Maeda S
Nihon Hinyokika Gakkai Zasshi; 1980 Dec; 71(12):1438-45. PubMed ID: 6164808
[No Abstract] [Full Text] [Related]
18. [Evaluation of plasma tumor markers in germinal tumors of the testis].
Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
[TBL] [Abstract][Full Text] [Related]
19. Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.
Suurmeijer AJ; Oosterhuis JW; Marrink J; De Bruin HW; Schraffordt Koops H; Sleijfer DT; Fleuren GJ
Oncodev Biol Med; 1983; 4(4):289-308. PubMed ID: 6188132
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of PS beta 1G and other tumor markers in germ cell tumors of the testis.
Blacker C; Feinstein MC; Roger M; Scholler R
Andrologia; 1981; 13(5):458-67. PubMed ID: 6274232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]